bioRxiv Science⌕ Search

Biology subjects

Fouquerel, E.

Publications and source records attributed to Fouquerel, E..

2 recordsLinked to original sources

Oxidative DNA lesions destabilize centromeres and drive chromosome instability

Centromeres are essential regions of the genome that ensure chromosome segregation during mitosis. Yet, they are also hotspots for chromosome breaks and rearrangements in cancer. The mechanisms underlying this fragility is not fully elucidated. Here we show that oxidative DNA damage destabilizes centromeres and promotes chromosome instability. Using a chemoptogenetic system to generate singlet oxygen locally at centromeres, we uncouple centromeric oxidative damage from global oxidative stress. We find that oxidative base lesions activate base excision repair at centromeres but slow DNA synthesis, destabilize CENP-A chromatin, and are converted into DNA breaks that can persist into subsequent cell cycles. Single cell time lapse imaging reveals that the cellular fate of centromeric DNA damage depends on the cell cycle phase during which the oxidative lesions occur. Lesions induced before and during replication primarily induce cell cycle delays and often drive the cells into a state of quiescence, whereas lesions arising after replication allow mitotic progression but compromise the proliferative capacity of daughter cells. Finally, in pre-tumorigenic cells, centromeric oxidative lesions lead to mitotic defects, aneuploidy, and whole-arm chromosome translocations. Collectively, we identify centromeres as cell cycle-sensitive DNA damage sensors and oxidative stress as a direct driver of centromere fragility and chromosome instability Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=186 HEIGHT=200 SRC="FIGDIR/small/717272v1_ufig1.gif" ALT="Figure 1"> View larger version (46K): org.highwire.dtl.DTLVardef@71f4e6org.highwire.dtl.DTLVardef@1853dcforg.highwire.dtl.DTLVardef@9cf133org.highwire.dtl.DTLVardef@19f7edf_HPS_FORMAT_FIGEXP M_FIG C_FIG

cell biology↗

Parkinson's disease linked LRRK2 G2019S drives oxidative nuclear DNA damage and PARP1 hyperactive signaling

LRRK2 mutations are the most common cause of autosomal-dominant Parkinsons disease (PD), with G2019S linked to both familial and sporadic PD. Although LRRK2-mediated mitochondrial DNA damage is implicated in PD, the contribution of nuclear DNA damage is less understood. Using CRISPR/Cas9-generated LRRK2G2019S/G2019S knock-in cells, we discovered increased sensitivity to oxidative and alkylating DNA-damaging agents compared to wild-type, consistent with compromised tolerance/repair of lesions processed by base excision repair (BER). The oxRADD assay revealed elevated endogenous oxidative nuclear base damage in LRRK2 mutant cells. Concomitantly, PARP1-dependent poly(ADP-ribose) (PAR) levels were markedly increased, with chromatin enrichment of PARP1 and BER factors (XRCC1, DNA ligase III) only in LRRK2G2019S/G2019S cells, indicating BER initiation, without successful resolution. LRRK2G2019S/G2019S cells displayed synthetic lethality with PARP-trapping inhibitors (olaparib) but tolerated PARP1 knockdown, suggesting cytotoxicity from stabilized PARP-DNA complexes rather than loss of catalytic activity. The SOD/catalase mimetic EUK-134 abrogated LRRK2 G2019S-dependent PAR accumulation, whereas the mitochondrial complex I inhibitor rotenone exacerbated PAR levels, linking reactive oxygen species (ROS) to BER dysfunction and PARP1 hyperactivation. Overall, we have identified a ROS-dependent PARP1 hyperactivation pathway that underlies LRRK2 G2019S-associated cellular vulnerability.

cell biology↗